$977 Million is the total value of Redmile Group, LLC's 47 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 56.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FOLD | Buy | AMICUS THERAPEUTICS INC | $90,571,000 | -9.2% | 10,718,420 | +4.3% | 9.27% | +24.2% |
| MDVN | Buy | MEDIVATION INC | $82,148,000 | +6.3% | 1,786,599 | +11.7% | 8.41% | +45.3% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $59,507,000 | -5.3% | 3,099,336 | +72.6% | 6.09% | +29.5% |
| PEN | Sell | PENUMBRA INC | $58,326,000 | -23.5% | 1,267,967 | -17.5% | 5.97% | +4.7% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $56,494,000 | -25.0% | 19,150,650 | +7.3% | 5.78% | +2.6% |
| IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $47,263,000 | +11.1% | 4,320,192 | +17.7% | 4.84% | +51.9% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $43,308,000 | +6.8% | 2,275,765 | +48.3% | 4.43% | +46.1% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $39,449,000 | – | 478,287 | +100.0% | 4.04% | – |
| SGEN | Sell | SEATTLE GENETICS INC | $34,042,000 | -44.7% | 970,121 | -29.3% | 3.48% | -24.4% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $33,760,000 | -39.6% | 1,053,018 | +9.9% | 3.46% | -17.4% |
| AGN | Buy | ALLERGAN PLC | $30,675,000 | +42.8% | 114,448 | +66.5% | 3.14% | +95.2% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $29,358,000 | -55.4% | 1,056,059 | -13.7% | 3.00% | -39.0% |
| CNC | Buy | CENTENE CORP DEL | $28,972,000 | +7.9% | 470,549 | +15.3% | 2.96% | +47.6% |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $28,355,000 | +42.0% | 1,863,035 | +37.2% | 2.90% | +94.1% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $25,065,000 | -39.6% | 1,332,520 | -40.8% | 2.56% | -17.4% |
| BKD | New | BROOKDALE SR LIVING INC | $22,691,000 | – | 1,428,931 | +100.0% | 2.32% | – |
| AET | New | AETNA INC NEW | $21,529,000 | – | 191,625 | +100.0% | 2.20% | – |
| MOH | New | MOLINA HEALTHCARE INC | $21,218,000 | – | 329,013 | +100.0% | 2.17% | – |
| ELGX | Buy | ENDOLOGIX INC | $20,640,000 | +107.0% | 2,468,847 | +145.1% | 2.11% | +183.1% |
| MODN | Buy | MODEL N INC | $20,305,000 | -2.6% | 1,885,359 | +0.9% | 2.08% | +33.2% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $18,148,000 | -63.2% | 889,607 | -7.2% | 1.86% | -49.7% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $16,963,000 | -7.4% | 1,238,273 | +2.0% | 1.74% | +26.6% |
| Sell | NEURODERM LTD | $16,674,000 | -38.5% | 1,180,887 | -25.7% | 1.71% | -15.8% | |
| INCY | Sell | INCYTE CORP | $15,697,000 | -59.6% | 216,594 | -39.5% | 1.61% | -44.7% |
| WOOF | New | VCA INC | $11,988,000 | – | 207,800 | +100.0% | 1.23% | – |
| New | CLOVIS ONCOLOGY INCcall | $11,520,000 | – | 600,000 | +100.0% | 1.18% | – | |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $9,413,000 | -34.7% | 729,699 | -1.2% | 0.96% | -10.7% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $8,682,000 | -12.2% | 876,088 | +1.8% | 0.89% | +20.1% |
| CFMS | Buy | CONFORMIS INC | $8,518,000 | +291.8% | 792,355 | +530.3% | 0.87% | +435.0% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $8,339,000 | -15.3% | 109,806 | -10.3% | 0.85% | +15.9% |
| NVRO | Sell | NEVRO CORP | $7,346,000 | -73.8% | 130,571 | -68.6% | 0.75% | -64.2% |
| NVTA | INVITAE CORP | $6,753,000 | +24.6% | 660,129 | 0.0% | 0.69% | +70.2% | |
| HTWR | New | HEARTWARE INTL INC | $6,748,000 | – | 214,771 | +100.0% | 0.69% | – |
| PGND | Sell | PRESS GANEY HLDGS INC | $6,564,000 | -13.2% | 218,214 | -8.9% | 0.67% | +18.7% |
| GWPH | New | GW PHARMACEUTICALS PLCads | $5,938,000 | – | 82,300 | +100.0% | 0.61% | – |
| EHTH | New | EHEALTH INC | $3,960,000 | – | 421,742 | +100.0% | 0.40% | – |
| PFE | PFIZER INC | $3,669,000 | -8.2% | 123,800 | 0.0% | 0.38% | +25.8% | |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $3,503,000 | – | 263,000 | +100.0% | 0.36% | – |
| ARRAY BIOPHARMA INCnote 3.000% 6/0 | $3,220,000 | -13.0% | 4,000,000 | 0.0% | 0.33% | +19.1% | ||
| DRRX | Sell | DURECT CORP | $3,142,000 | -45.9% | 2,327,137 | -11.5% | 0.32% | -26.0% |
| PRQR | Sell | PROQR THRAPEUTICS N V | $2,697,000 | -44.2% | 552,713 | -0.8% | 0.28% | -23.8% |
| FATE | Sell | FATE THERAPEUTICS INC | $2,677,000 | -66.5% | 1,486,980 | -37.3% | 0.27% | -54.2% |
| IHF | ISHARES TRus hlthcr pr etf | $551,000 | -2.0% | 4,520 | 0.0% | 0.06% | +33.3% | |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $488,000 | -93.3% | 27,055 | -90.2% | 0.05% | -90.8% |
| AXGT | New | AXOVANT SCIENCES LTD | $115,000 | – | 10,000 | +100.0% | 0.01% | – |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $58,000 | +41.5% | 19,710 | +18.7% | 0.01% | +100.0% |
| CCXI | Sell | CHEMOCENTRYX INC | $25,000 | -95.1% | 10,000 | -84.2% | 0.00% | -92.1% |
| CSLT | Exit | CASTLIGHT HEALTH INCcl b | $0 | – | -10,229 | -100.0% | -0.00% | – |
| AXDX | Exit | ACCELERATE DIAGNOSTICS INC | $0 | – | -10,000 | -100.0% | -0.02% | – |
| AAVL | Exit | AVALANCHE BIOTECHNOLOGIES IN | $0 | – | -24,236 | -100.0% | -0.02% | – |
| ADRO | Exit | ADURO BIOTECH INC | $0 | – | -10,436 | -100.0% | -0.02% | – |
| DBVT | Exit | DBV TECHNOLOGIES S Asponsored adr | $0 | – | -7,994 | -100.0% | -0.02% | – |
| XBI | Exit | SPDR SERIES TRUSTs&p biotech | $0 | – | -4,530 | -100.0% | -0.02% | – |
| FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -32,561 | -100.0% | -0.03% | – |
| DNAI | Exit | PRONAI THERAPEUTICS INC | $0 | – | -24,787 | -100.0% | -0.03% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -10,055 | -100.0% | -0.09% | – |
| EBIO | Exit | ELEVEN BIOTHERAPEUTICS INC | $0 | – | -875,857 | -100.0% | -0.20% | – |
| ONTY | Exit | ONCOTHYREON INC | $0 | – | -2,331,300 | -100.0% | -0.39% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -218,718 | -100.0% | -0.53% | – |
| TRIV | Exit | TRIVASCULAR TECHNOLOGIES INC | $0 | – | -1,462,762 | -100.0% | -0.73% | – |
| HNT | Exit | HEALTH NET INC | $0 | – | -181,029 | -100.0% | -0.93% | – |
| ZLTQ | Exit | ZELTIQ AESTHETICS INC | $0 | – | -709,426 | -100.0% | -1.52% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -187,034 | -100.0% | -1.65% | – |
| INSM | Exit | INSMED INC | $0 | – | -1,391,813 | -100.0% | -1.89% | – |
| DPLO | Exit | DIPLOMAT PHARMACY INC | $0 | – | -1,115,902 | -100.0% | -2.86% | – |
| Exit | PFIZER INCcall | $0 | – | -1,260,400 | -100.0% | -3.04% | – | |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -562,873 | -100.0% | -3.29% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDadr | $0 | – | -938,139 | -100.0% | -4.61% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.